𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patients

✍ Scribed by Marc Wirden; Anne Genevieve Marcelin; Anne Simon; Myriam Kirstetter; Roland Tubiana; Marc-Antoine Valantin; Luc Paris; Manuela Bonmarchand; Francoise Conan; Laurence Kalkias; Christine Katlama; Vincent Calvez


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
66 KB
Volume
76
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Diverse pattern of protease inhibitor re
✍ Veronica Svedhem; A. Lindkvist; T. Bergroth; Lidman Knut; A. Sönnerborg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

## Abstract The aim of the study was to describe the pattern of resistance mutations in human immunodeficiency virus type 1 (HIV‐1) infected patients experiencing their first protease inhibitor (PI) failure on nelfinavir (NFV)‐containing therapy. Earlier PI‐naïve patients (n = 172) with NFV‐contain

Lopinavir/ritonavir resistance in patien
✍ Karen Champenois; Agathe Baras; Philippe Choisy; Faiza Ajana; Hughes Melliez; La 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

## Abstract The HIV‐1 protease L76V mutation has been described recently as conferring high‐level resistance to lopinavir/ritonavir (LPV/r). The aim was to identify the factors and particularly protease mutations associated with the presence of L76V in treatment‐experienced patients infected with H

Relationship between mutations in HIV-1
✍ Bénédicte Roquebert; Marc Wirden; Anne Simon; Jérome Deval; Christine Katlama; V 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

## Abstract Recent studies have highlighted the need of investigating the in vivo role of ribonuclease H (RNase H) in nucleoside reverse transcriptase inhibitors (NRTIs) resistance. The prevalence of RNase H mutations in naive and in NRTI pre‐treated patients in regimen failure were compared and so

HIV-1 genotype resistance pattern and ev
✍ E. Quiros-Roldan; F. Moretti; C. Torti; V. Tirelli; S. Casari; G. Carosi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Clinical and in vitro studies have suggested that nelfinavir (NFV)-containing regimens may not preclude the use of other protease inhibitors (PIs) in treatment sequencing. We have studied the prevalence of 30N mutation in a human immunodeficiency virus-1 (HIV-1)-infected cohort and the virological r

Lamivudine resistance mutations in Europ
✍ Lucia Taramasso; Patrizia Caligiuri; Antonio Di Biagio; Bianca Bruzzone; Raffael 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

## Abstract Evaluation of resistance pattern in patients with chronic hepatitis B. Retrospective study of hepatitis B virus (HBV) resistance mutations in patients found viraemic after first‐line treatment. HBV viral load was determined by a real‐time polymerase chain reaction and the substitutions